Protecting Stimulator Leads During the Trial Period Prevented Lead Migration

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published January 13, 2026 | Category: Pain Medicine

Before a spinal cord stimulator (SCS) is permanently implanted, most patients have a trial period of several weeks. In some practices, the leads placed during the trial stay in and are later connected to the permanent battery. Scar tissue that forms around the leads during the trial can make that second surgery harder and can pull leads out of position. A 2025 study in Pain Practice described a technique designed to prevent this.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

The authors reviewed 174 patients who had SCS trials at one Italian center from 2017 to 2022.

  • During the trial surgery, small pieces of synthetic dural substitute (the "confetti" technique) were placed to protect the leads from scar tissue.
  • The leads stayed connected to an external generator for about 3 weeks (mean 21.4 days).
  • At the second surgery, the leads were freed from the dural substitute and connected to the implanted battery.
  • Complications and surgery times were compared with patients treated before the technique was introduced.

What they found

  • No technique-related complications occurred during the trial period after the technique was adopted. Before 2017, 3.9% of patients had lead migration from scarring that required re-implantation.
  • Average surgery time fell from 54 minutes to 32 minutes.
  • 85.1% of patients went on to permanent implantation, with a mean follow-up of 52 months.
  • Medical complications included infection (2.1%) and wound breakdown (1.3%).

Why this matters

Lead migration means another operation, more anesthesia and more infection risk. Shorter surgery also means less time with an open wound. A simple barrier that keeps scar tissue off the leads addresses both problems.

Limitations

This was a retrospective, single-center study comparing two time periods, so other changes in practice may have played a role. It applies mainly to trial methods in which trial leads are kept for the permanent implant.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • If your trial technique keeps leads in place for the permanent implant, consider strategies that protect leads from scar formation.
  • Track lead migration, revision and surgery times so you can see whether a technique change is working.
  • Keep infection prevention front and center, since trial leads that exit the skin carry their own risk.

For hospitals, clinics and safety leaders

  • Include lead migration and unplanned revision as quality measures for neuromodulation programs.

For patients and families

  • Ask how your trial is done and what will happen to the trial leads if you go on to a permanent implant.
  • Report any change in where you feel stimulation, wound drainage or fever during the trial.

Reference

  1. Dario A, Ferlendis L, Bossi B, Locatelli D. Preventing technique-related complications in spinal cord stimulation trials: The Dural Substitute Confetti technique. A retrospective monocentric analysis. Pain Pract. 2025 Jan;25(1):e13426. doi:10.1111/papr.13426. PMID: 39435724. PubMed: https://pubmed.ncbi.nlm.nih.gov/39435724/

This article is educational information, not legal or medical advice.


Previous
Previous

Ultrasound Let Physicians See and Avoid Blood Vessels During Cervical Medial Branch Blocks

Next
Next

A Planned Fluid Protocol Prevented Low Blood Pressure After Nerve Neurolysis for Cancer Pain